Acomplia is a drug to assist obese people to lose weight and it is approved for sale Europe and UK with prescription from 28th June 2006. Since that time, this drug acomplia rimonabant is called a miracle drug for obesity treatment. Acomplia Rimonabant has been manufactured by Sanofi Aventis , a french pharmaceuticals.
How Acomplia Rimonabant Works?
Acomplia Rimonabant works by blocking the CB1 receptor in the body's endocannabinoid system. The endocannabinoid system is thought to regulate the body's desire for food and energy consumption. The body sends out chemicals called cannabinoids which, when they latch onto the CB1 receptors which are located in fat cells and the hypothalamus of the brain, creates a signal that the body desires food and this manifests itself as hunger pangs. It is believed that the endocannabinoid system is overactive in overweight and obese people. The blocking of the CB1 receptor by Rimonabant (the active ingredient in Acomplia) makes hunger pangs much more manageable.
Acomplia Rimonabant's clinical trials
As with most drug treatment, acomplia-rimonabant/Acomplia Rimonabant does not work for everyone. Clinical trials of this drug Acomplia Rimonabant demonstrated that 70% of patients were able to lose at least 5% of their body weight over a 12 month period. Around 39% of patients who took acomplia rimonabant managed to lose at least 10% of their bodyweight over the same period. It was also noted that most of the weight loss occurred within the first nine months of this acomplia rimonabant's treatment.
Acomplia Rimonabant Side Effects
Rimonabant Acomplia is not without potential side effects like all other drugs. The most common side effects reported by patients taking acomplia rimonabant include nausea, depression, irritability and sleeplessness. Most patients with Acomplia rimonabant's treatment have reported no side effects whatsoever and only a handful have considered the side effects to be so serious that they have decided to cease Acomplia Rimonabant treatment.
What is Chantix (Champix)?
Chantix (Champix) is a new drug by world famous Pfizer pharmaceuticals, which has recently been approved for Smoking cessation. Chantix (Varenicline) enables smokers to see the light at the end of the tunnel, where they can live a healthy life sans smoking. Smoking is one habit difficult to kick; leaving no escape route for a smoker once he becomes nicotine dependent. Smoking cessation therapies are more likely to succeed for patients who are motivated to stop smoking and who are provided with additional advice and support.
Chantix is for oral use. The recommended dose is 1 mg Chantix (Champix/varenicline) twice daily.
Chantix (Champix) Side Effects Includes following of them:
